Research indicates that mesenchymal stem cells (MSCs) can mitigate rheumatoid arthritis by lowering miR-548e levels and suppressing IκB translation, which in turn diminishes NF-κB signaling activity and alleviates inflammation (73). This evidence concerns the gene NFKB1 and rheumatoid arthritis.